These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis. Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis. D'Alessandro-Gabazza CN; Yasuma T; Kobayashi T; Toda M; Abdel-Hamid AM; Fujimoto H; Hataji O; Nakahara H; Takeshita A; Nishihama K; Okano T; Saiki H; Okano Y; Tomaru A; Fridman D'Alessandro V; Shiraishi M; Mizoguchi A; Ono R; Ohtsuka J; Fukumura M; Nosaka T; Mi X; Shukla D; Kataoka K; Kondoh Y; Hirose M; Arai T; Inoue Y; Yano Y; Mackie RI; Cann I; Gabazza EC Nat Commun; 2022 Mar; 13(1):1558. PubMed ID: 35322016 [TBL] [Abstract][Full Text] [Related]
4. Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice. Moyé S; Bormann T; Maus R; Sparwasser T; Sandrock I; Prinz I; Warnecke G; Welte T; Gauldie J; Kolb M; Maus UA J Immunol; 2020 May; 204(9):2429-2438. PubMed ID: 32213566 [TBL] [Abstract][Full Text] [Related]
8. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis. Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485 [TBL] [Abstract][Full Text] [Related]
9. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis. Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648 [TBL] [Abstract][Full Text] [Related]
10. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747 [No Abstract] [Full Text] [Related]
11. Increased Galectin-9 Concentration and Number of CD4+Foxp3high+Cells in Bronchoalveolar Lavage Fluid of Patients with Cryptogenic Organizing Pneumonia. Katoh S; Ikeda M; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Oka M Lung; 2015 Oct; 193(5):683-9. PubMed ID: 26249221 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis. Gui X; Qiu X; Tian Y; Xie M; Li H; Gao Y; Zhuang Y; Cao M; Ding H; Ding J; Zhang Y; Cai H Int Immunopharmacol; 2019 May; 70():208-215. PubMed ID: 30851700 [TBL] [Abstract][Full Text] [Related]
13. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis. Zhang L; Li Y; Liang C; Yang W Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150 [TBL] [Abstract][Full Text] [Related]
14. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF. Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543 [TBL] [Abstract][Full Text] [Related]
15. Development and preclinical efficacy of novel transforming growth factor-β1 short interfering RNAs for pulmonary fibrosis. D'Alessandro-Gabazza CN; Kobayashi T; Boveda-Ruiz D; Takagi T; Toda M; Gil-Bernabe P; Miyake Y; Yasukawa A; Matsuda Y; Suzuki N; Saito H; Yano Y; Fukuda A; Hasegawa T; Toyobuku H; Rennard SI; Wagner PD; Morser J; Takei Y; Taguchi O; Gabazza EC Am J Respir Cell Mol Biol; 2012 Mar; 46(3):397-406. PubMed ID: 22033267 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β Togami K; Yamaguchi K; Chono S; Tada H J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice. Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951 [TBL] [Abstract][Full Text] [Related]
19. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Han MK; Zhou Y; Murray S; Tayob N; Noth I; Lama VN; Moore BB; White ES; Flaherty KR; Huffnagle GB; Martinez FJ; Lancet Respir Med; 2014 Jul; 2(7):548-56. PubMed ID: 24767767 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. Hagimoto N; Kuwano K; Inoshima I; Yoshimi M; Nakamura N; Fujita M; Maeyama T; Hara N J Immunol; 2002 Jun; 168(12):6470-8. PubMed ID: 12055267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]